ArticleClinical and translational radiation oncology2022

PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.

Julia Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.